學(xué)校介紹
中國(guó)藥科大學(xué)坐落于古都南京，始建于1936年，是我國(guó)歷史上第一所由國(guó)家創(chuàng)辦的藥學(xué)高等學(xué)府。學(xué)校為教育部直屬、國(guó)家“211工程”和“985工程優(yōu)勢(shì)學(xué)科創(chuàng)新平臺(tái)”建設(shè)高校，是一所以藥學(xué)為特色的多科性、研究型大學(xué)，素有“中國(guó)生物醫(yī)藥人才搖籃”的美譽(yù)。2017年，成為國(guó)家“雙一流”建設(shè)高校。
學(xué)?，F(xiàn)有中國(guó)工程院院士1人、德國(guó)科學(xué)院院士1人，國(guó)家級(jí)高層次人才19人次，國(guó)家級(jí)高層次青年人才81人次。學(xué)校致力于建設(shè)以“藥學(xué)+X”為牽引、“新藥科”和“大藥學(xué)”為特征，醫(yī)藥、農(nóng)藥、獸藥融合發(fā)展，面向世界一流的“現(xiàn)代藥學(xué)學(xué)科體系2.0”?，F(xiàn)有16個(gè)院部，31個(gè)本科專業(yè)（類），4個(gè)一級(jí)學(xué)科博士學(xué)位授權(quán)點(diǎn)（藥學(xué)、中藥學(xué)、生物學(xué)、生物醫(yī)學(xué)工程），2個(gè)博士專業(yè)學(xué)位授權(quán)點(diǎn)（生物與醫(yī)藥、藥學(xué)），8個(gè)一級(jí)學(xué)科碩士學(xué)位授權(quán)點(diǎn)，6個(gè)碩士專業(yè)學(xué)位授權(quán)點(diǎn)，2個(gè)博士后流動(dòng)站（藥學(xué)、中藥學(xué)）
學(xué)院簡(jiǎn)介
中國(guó)藥科大學(xué)國(guó)際醫(yī)藥商學(xué)院創(chuàng)院于1993年，依托學(xué)校醫(yī)藥領(lǐng)域的學(xué)科優(yōu)勢(shì)，致力于培養(yǎng)具有國(guó)際視野的高層次醫(yī)藥經(jīng)濟(jì)與管理人才，打造藥物經(jīng)濟(jì)學(xué)、衛(wèi)生事業(yè)管理公共政策等學(xué)科研究的高地。學(xué)院現(xiàn)設(shè)有工商管理學(xué)系、經(jīng)濟(jì)貿(mào)易系、藥事管理系、公共管理系、醫(yī)藥經(jīng)濟(jì)管理綜合實(shí)驗(yàn)中心和MPA教育中心。學(xué)院教職工80人，專任教師61人，其中正高級(jí)職稱14人，副高級(jí)職稱29人?，F(xiàn)有社會(huì)與管理藥學(xué)、藥物經(jīng)濟(jì)學(xué)2個(gè)學(xué)術(shù)學(xué)位博士點(diǎn)，藥學(xué)博士（管理藥學(xué)）1個(gè)專業(yè)學(xué)位博士點(diǎn)，社會(huì)與管理藥學(xué)、藥物經(jīng)濟(jì)學(xué)、公共管理3個(gè)學(xué)術(shù)學(xué)位碩士點(diǎn)，藥學(xué)碩士、公共管理碩士2個(gè)專業(yè)學(xué)位碩士點(diǎn)。近五年來，學(xué)院獲批國(guó)家自然科學(xué)基金及國(guó)家社會(huì)科學(xué)基金13項(xiàng)，承接衛(wèi)健委、醫(yī)保局、藥監(jiān)局、發(fā)改委、工信部等國(guó)家、省部委事業(yè)單位，以及知名藥企委托的科研課題超1300項(xiàng)，發(fā)表核心期刊以上論文700余篇，其中高水平SCI/SSCI論文數(shù)量顯著提升，科研成果豐碩。為進(jìn)一步推動(dòng)學(xué)院學(xué)科建設(shè)和國(guó)際化發(fā)展，現(xiàn)面向海內(nèi)外公開招聘優(yōu)秀人才，誠(chéng)邀有志之士加盟。
招聘方向
藥物經(jīng)濟(jì)學(xué)、臨床預(yù)測(cè)、監(jiān)管科學(xué)、公共政策、衛(wèi)生事業(yè)管理、生物統(tǒng)計(jì)等學(xué)科領(lǐng)域。
引進(jìn)層次
1.興藥領(lǐng)軍學(xué)者
引進(jìn)條件：一般應(yīng)在海外知名高校、科研院所取得助理教授崗位或特別優(yōu)秀的博士后研究人員；年齡一般不超過40周歲；具備承擔(dān)國(guó)家級(jí)重大科研項(xiàng)目的潛力，在相關(guān)領(lǐng)域取得有影響力的標(biāo)志性成果。
2.興藥青創(chuàng)學(xué)者
引進(jìn)條件：年齡男不超過35周歲，女不超過38周歲；一般應(yīng)在國(guó)內(nèi)外知名高校取得博士學(xué)位；具備承擔(dān)國(guó)家級(jí)科研項(xiàng)目的能力，在相關(guān)領(lǐng)域取得有影響力的標(biāo)志性成果。
3.副教授/特聘副研究員
引進(jìn)條件：年齡不超過35周歲；一般應(yīng)在國(guó)內(nèi)外知名高校取得博士學(xué)位；具備承擔(dān)國(guó)家級(jí)科研項(xiàng)目的能力，在國(guó)內(nèi)外知名期刊發(fā)表過高水平學(xué)術(shù)論文或取得其他高質(zhì)量的科研成果。
4.講師
引進(jìn)條件：年齡不超過35周歲；一般應(yīng)在國(guó)內(nèi)外知名高校取得博士學(xué)位；具備較強(qiáng)科研創(chuàng)新潛力，在國(guó)內(nèi)外知名期刊發(fā)表過高水平學(xué)術(shù)論文或取得其他高質(zhì)量的科研成果。
應(yīng)聘材料及聯(lián)系方式
請(qǐng)將個(gè)人簡(jiǎn)歷、學(xué)位學(xué)歷證書、未來5-10年工作計(jì)劃（1000字以內(nèi)）發(fā)送至郵箱sxy@cpu.edu.cn（郵件標(biāo)題請(qǐng)注明應(yīng)聘崗位+姓名+研究方向”）。簡(jiǎn)歷應(yīng)包括個(gè)人基本信息、學(xué)習(xí)及工作經(jīng)歷、主要學(xué)術(shù)成果（論文、項(xiàng)目和獎(jiǎng)勵(lì)情況等）
聯(lián)系人：中國(guó)藥科大學(xué)國(guó)際醫(yī)藥商學(xué)院 劉老師 025-86185038
中國(guó)藥科大學(xué)國(guó)際醫(yī)藥商學(xué)院
2025年4月3日
University Overview
China Pharmaceutical University (CPU), founded in 1936 in Nanjing, is China’s first state-established institution of higher education in pharmacy. As a Ministry of Education-affiliated university, CPU is a member of the national "Project 211" and "985 Project Innovation Platform".Renowned as the "Cradle of China’s Biopharmaceutical Talents," CPU is a multidisciplinary, research-intensive university with distinctive strengths in pharmacy. In 2017, CPU was selected into the national "Double First-Class" initiative .
The university currently boasts 1 Chinese Academy of Engineering academician, 1 German National Academy of Sciences academician, 19 national high-level talents, and 81 national high-level young talents. CPU is committed to building a world-class "Modern Pharmacy Discipline System 2.0", characterized by the integration of "Pharmacy+X" interdisciplinary approaches, the development of "New Pharmacy" and "Comprehensive Pharmacy," and the coordinated advancement of Pharmacy, Pesticide science, and Veterinary pharmacy. The university has 16 schools and departments, 31 undergraduate programs (categories), 4 first-level discipline doctoral degree authorization points (Pharmacy, Traditional Chinese medicine, Biology, and Biomedical engineering), 2 professional doctoral degree authorization points (Biology and medicine, pharmacy), 8 first-level discipline masters degree authorization points, 6 professional master’s degree authorization points, and 2 postdoctoral research stations (Pharmacy and Traditional Chinese medicine).
School Overview
Established in 1993, the International Pharmaceutical Business School (IPBS) leverages CPU’s strengths in pharmaceutical disciplines to cultivate high-level professionals with global perspectives in pharmaceutical economics and management, and committed to building a high ground for research in pharmacoeconomics, healthcare management, and public policy. IPBS comprises the Department of Business Administration, the Department of Economics and Trade, the Department of Pharmaceutical Administration, the Department of Public Administration, the Comprehensive Experimental Center of Pharmaceutical Economic Management, and the MPA Education Center. With 80 faculty members, including 61 full-time teachers (14 senior titles and 29 associate senior titles), the school offers 2 academic doctoral programs (Social & Administrative Pharmacy and Pharmacoeconomics), 1 professional doctoral program (Pharmacy—Administrative Pharmacy), 3 academic master’s programs (Social & Administrative Pharmacy, Pharmacoeconomics, and Public Administration), and 2 professional master’s programs (Pharmacy and Public Administration).
Over the past five years, IPBS has secured 13 National Natural/Social Science Foundation-funded projects and undertaken over 1,300 research projects commissioned by national ministries, agencies (e.g., National Health Commission, Medical Insurance Bureau, Food and Drug Administration, Development and Reform Commission, Ministry of Industry and Information), and leading pharmaceutical enterprises. Faculty members have published over 700 papers in core journals, with a significant increase in high-quality SCI/SSCI publications. To advance disciplinary development and internationalization, IPBS now invites applications from outstanding global scholars.
Recruitment Research Fields
Pharmacoeconomics, Clinical Prediction, Regulatory Science, Public Policy, Healthcare Management, Biostatistics, and related disciplines.
Positions and Requirements
1.Xing Yao Leading Scholars
Qualifications: Assistant Professor (or exceptional postdoctoral researcher) from an internationally renowned global university or research institution; typically under 40 years old; demonstrated capacity to lead major national-level research projects and achieved influential landmark academic achievements.
2.Xing Yao Young Innovative Scholars
Qualifications: PhD from an internationally renowned global university or research institution; male candidates under the age of 35, female candidates under the age of 38; with the ability to undertake national-level research projects and produce influential academic achievements.
3.Associate Professor (tenure track)/University Appointed Associate Professor
Qualifications: PhD from an internationally renowned global university or research institution; under the age of 35; proven capacity to undertake national-level research projects, with high-quality publications in top-tier journals or equivalent academic contributions.
4.Lecturer
Qualifications: PhD from an internationally renowned global university or research institution; under the age of 35; demonstrated strong potential for scientific research, with publications in prestigious journals or other notable academic achievements.
How to apply
Application Materials
1）Curriculum Vitae (including personal details, education/employment history, and major academic achievements such as publications, grants, and awards).
2）Degree/Diploma Certificates.
3）5-10 Year Research Plan (within 1,000 words).
Please submit the above materials tosxy@cpu.edu.cn (email subject: Position +Name+Research Field).
Contact Information
Mr. Liu, International Pharmaceutical Business School
Tel: +86-25-86185038
China Pharmaceutical University
International Pharmaceutical Business School
April 3, 2025
詳見：http://www.scitoday.cn/talent/info.aspx?id=11991
熱門跟貼